Immune Pharmaceuticals
New York, US
Founders & leadership
DG
Daniel G. TeperChairman and Chief Executive Officer
Board
RL
Rene LererBoard director
AS
Ana StancicBoard director
DK
Daniel KazadoBoard director
DS
David SidranskyBoard director
IK
Isaac KobrinBoard director
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 1 round · 2014
▶$11.7MraisedApr 2014 · 42 investors · PharmaceuticalsRule 506(b)
▶$11.7MraisedApr 2014 · 42 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rene LererDirector
- Ana StancicDirector
- Daniel KazadoDirector
- Daniel G. TeperExecutive Officer, Director
- David SidranskyDirector
- Isaac KobrinDirector
- Offering amount
- $11.7M
- Amount sold
- $11.7M
- Sales commissions
- $544.6K
- Placement agents
- Chardan Capital Markets LLC
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Immune Pharmaceuticals?
- Immune Pharmaceuticals was founded by Daniel G. Teper.
- How much funding has Immune Pharmaceuticals raised?
- Immune Pharmaceuticals has disclosed $11.7M raised across 1 round.
- Where is Immune Pharmaceuticals headquartered?
- Immune Pharmaceuticals is headquartered in New York, US.